In Re The Detention Of: V.s. ( 2019 )

Filed
Washington State
Court of Appeals
Division Two
December 17, 2019
IN THE COURT OF APPEALS OF THE STATE OF WASHINGTON
DIVISION II
In the Matter of the Detention of: No. 51911-9-II
V.S. (Consolidated with
No. 52375-2-II)
Appellant UNPUBLISHED OPINION
LEE, A.C.J. — V.S. appeals from the superior court’s involuntary medication orders. V.S.
argues that (1) the State failed to meet its burden to prove a compelling state interest, (2) the State
failed to present sufficient evidence to show involuntary medication was necessary and effective,
(3) the superior court applied the wrong legal standard for involuntary medication, and (4) the
superior court’s orders are invalid because they failed to direct the maximum dosage to be
administered by the State. We affirm.
FACTS
In April 2017, V.S. was detained on an emergency basis because she was gravely disabled.
The superior court then held a hearing and entered a 14-day involuntary treatment order. V.S.
remained in involuntary commitment at Western State Hospital.
In September 2017, Dr. Shawn Noor filed a petition for treatment with involuntary
antipsychotic medication. However, the superior court denied the petition for involuntary
medication because the State had failed to meet its burden.
No. 51911-9-II (Consolidated with No. 52375-2-II)
In December 2017, Dr. Jaime Stevens filed another petition for treatment with involuntary
antipsychotic medication. At a hearing before the superior court commissioner, Dr. Stevens
testified that V.S. was currently diagnosed with unspecified psychotic disorder, rule out minor
cognitive disorder, delusional disorder by history, borderline traits, and major depressive disorder
by history. Dr. Stevens also testified that V.S. refused to take antipsychotic medication because
she did not believe that she had any mental illness.
Dr. Stevens explained that not administering the medication would likely result in harm
because V.S.’s refusal to take her medication and to effectively treat her diabetes was the direct
result of her psychosis and delusions. Dr. Stevens stated that failure to administer the antipsychotic
medication would substantially prolong V.S.’s commitment at Western State Hospital.
Dr. Stevens also explained that the likely benefits of antipsychotic medication would be a
reduction of delusions and an increase in rational thinking that would likely increase her rational
participation in medical decisions and make her better able to better care for herself. Dr. Stevens
testified regarding the relationship between V.S.’s delusions, her current medical condition, and
the proposed medication:
[Assistant Attorney General (AAG):] . . . Okay. Do you think if these
medications are not administered that there’s a likely (inaudible) harm to herself?
[Dr. Stevens:] Absolutely.
[AAG:] And how do you arrive at that conclusion?
[V.S., interrupting:] Because I’m so f***ing smart.
[Dr. Stevens:] So [V.S.]’s refusal to take—
[V.S., interrupting:] SMS.
2
No. 51911-9-II (Consolidated with No. 52375-2-II)
[Dr. Stevens:] [V.S.]’s refusal to take her medication for—and be evaluated
for her somatic conditions, her diabetes, her hyponatremia, et cetera, is a direct
result of her psychosis and a delusion that she knows better than the medical
community and has alternate ranges of acceptable in terms of her blood work.
If that delusion—if those delusions were improved by the medications, she
would be able to reason and make safer decisions, which would put her at much
less risk for coma, kidney dialysis, loss of vision, further loss of vision, further
neuropathy, loss of limb.
[V.S., interrupting:] There is [sic] no medical problems (inaudible)
and has never been.
[AAG:] . . . Do you think if these medications were not administered, she
would suffer a deterioration of routine function?
[Dr. Stevens:] Yes.
[AAG:] And how do you arrive at that conclusion?
[Dr. Stevens:] Those are the natural course of these diagnoses which she
has.
[V.S., interrupting]: B***sh**.
[Dr. Stevens:] Untreated diabetes can lead to an elevated hemoglobin A1C,
caused glycosylated proteins in her blood, which she already has. Those are—those
can directly result in, like I said, loss of vision, loss of limb, worsening neuropathy,
kidney (inaudible).
[AAG:] . . . Okay. Do you think a failure to administer these medications
would substantially prolong her stay here at Western State?
[Dr. Stevens:] Yes, because all of those medical complications would have
to be dealt with at an inpatient level.
[AAG:] Okay. What is your prognosis if these medications are
administered?
[V.S., interrupting:] I’ll just die.
[Dr. Stevens:] Fair.
3
No. 51911-9-II (Consolidated with No. 52375-2-II)
[AAG:] . . . Okay. But what do you mean by “fair”?
[Dr. Stevens:] I think it’s very likely that her willingness to care for herself
would be improved if she was able to think more rationally. I think that she might
continue to have some delusions, although oftentimes the edge is taken off of those
and they are less intense and there is an ability to sort of engage in therapeutic
milieu as well as engage in conversation with the internist and medical providers to
weigh risks and benefits of medical care.
[AAG:] And what’s your prognosis if these are not administered?
[Dr. Stevens:] Expedited death.
2 Verbatim Report of Proceedings (VRP) at 116-18. And Dr. Stevens testified that the medications
were medically necessary and appropriate. 2 VRP 119. Dr. Stevens explained that,
The only other evidence we have for treating [V.S.’s] diagnosis is psychotherapy,
and we are offering her that and she is refusing that. I do believe, though, that once
her—once she is able to reason and able to participate in her care when her thought
process is organized by the medications, she will be able to engage in the
psychotherapy process.
2 VRP at 119.
The superior court commissioner granted the petition in part. In its oral ruling, the
commissioner explained that the issue comes down to the V.S.’s diabetes, which was described as
being severe, and testimony that V.S. has refused “24 out of 28 doses of insulin.” 2 VRP at 151.
The commissioner stated:
I am not convinced by the testimony of [V.S.] who basically says, “Hell if I know,”
to whether there’s a diabetes diagnosis or not or whether it’s appropriate, but the
refusal of both the finger sticks and the insulin is likely to be life threatening, and
that is reason, I believe, that—
[V.S.]: Did you see all those finger sticks?
[Commissioner]: I believe that it is reason sufficient to enter the order in
this case with no less restrictives being available at present.
4
No. 51911-9-II (Consolidated with No. 52375-2-II)
2 VRP at 151-52.
The superior court commissioner’s December 28, 2017, written Findings of Fact,
Conclusions of Law, and Order Authorizing Involuntary Treatment With Antipsychotic
Medications found four compelling state interests justifying the use of antipsychotic medication:
4. Reasons for the Use of Antipsychotic Medication. The Petitioner has a
compelling interest in administering antipsychotic medication to the Respondent
for the following reasons:
Respondent has recently threatened, attempted or caused serious harm to
self or others and treatment with antipsychotic medication will reduce the
likelihood that Respondent will commit serious harm to self or others;
(ISSUES WITH PHYSICAL HEALTH INCLUDING DIABETES
WHICH IS ALREADY GETTING SEVERE). Respondent believes that
she has a special condition because she is from the British Isles that will
cause her to break out in boils from having certain diabetes treatment(s). Is
refusing her glucose shots (refused 24 of 28 doses of insulin). Refuses
finger sticks for blood glucose. Mostly caused by delusion(s).
Respondent has suffered or will suffer a severe deterioration in routine
functioning that endangers Respondent’s health or safety if he/she does not
receive such treatment, as evidenced by Respondent’s past behavior and
mental condition while he/she was receiving such treatment.
Respondent will likely be detained for a substantially longer period of time,
at increased public expense, without such treatment.
Other: Hope is that the medications will help alleviate her delusions and
allow rational choices including for her physical health. She could treat her
issues with psychotherapy but currently refuses to take part in it due to
mental illness. Had been treated with an anti-psychotic (Olanzapine) in the
community—St. Clare and Harrison Hospital. . .(when this is said the
respondent says “bull***t”).
5. Less Effective Alternatives. Antipsychotic medication is a necessary and
effective course of treatment for the Respondent, as evidence by Respondent’s
prognosis with and without this treatment and the lack of effective alternative
courses of treatment. The alternatives are less effective than medication for the
following reasons:
5
No. 51911-9-II (Consolidated with No. 52375-2-II)
They are more likely to prolong the length of commitment for involuntary
treatment;
....
Other: If medication is administered then she is likely to make more rational
decisions, particularly about her medical situations. If not administered she
is likely to have serious health concerns, including death. Physical health
has already deteriorated to point of starting to affect her.
Clerk’s Papers (CP) at 73-74. The commissioner made the findings by clear, cogent, and
convincing evidence. The commissioner’s written order concluded that
10. The Respondent may be involuntarily treated with antipsychotic medication
and side effect medication at clinically appropriate levels over his/her objections
and over his/her express refusal for the period of the current involuntary treatment
order, and any interim period during which he/she is awaiting trial or hearing on a
new petition for involuntary treatment or involuntary medication.
CP at 74. Accordingly, the commissioner ordered:
11. Antipsychotic Medication. The petitioner and Western State Hospital are
hereby authorized to administer:
Antipsychotic medications as requested in the Petition; or
Other: No Olanzapine without another court order/hearing;
and side effect medications at clinically appropriate levels to the Respondent over
his/her objections and over his/her express refusal.
CP at 74.
V.S. moved to revise the commissioner’s order. In its January 26, 2018, order, the superior
court adopted and incorporated the commissioner’s written order and denied V.S.’s motion to
revise.
In February 2018, Dr. Maya Kumar filed a third petition for involuntary treatment with
antipsychotic medication. At the hearing, Dr. Kumar testified that V.S.’s current diagnosis was
6
No. 51911-9-II (Consolidated with No. 52375-2-II)
changed to schizoaffective disorder but that V.S. had an extensive psychiatric history. Dr. Kumar
also testified that since the last medication order was put in place, V.S. was much more cooperative
and her condition had significantly improved. Prior to the medication, V.S. was refusing medical
treatment for her diabetes, but the medication made a significant difference. After the medication,
V.S.’s attitude improved and she became more cooperative. However, Dr. Kumar explained that
V.S. was on risperidone and that Dr. Kumar would like to continue administering the same
medication that V.S. has improved on. Dr. Kumar stated, however, that if V.S. is not under court
order, based on what V.S. told her, V.S. will discontinue using risperidone.
Dr. Kumar further testified that if V.S. stopped taking the antipsychotic medication she
would expect that V.S. would revert to the prior condition—refusing blood sugar checks and
insulin treatment. Dr. Kumar also stated that she was not aware of any less intrusive treatments
that would be effective for treating V.S. because it was the administration of medication that
caused the degree of improvement.
On March 1, the superior court commissioner granted the petition for involuntary
medication. In its oral ruling the superior court commissioner found that the necessity for the
administration of antipsychotic medication had been shown by clear, cogent, and convincing
evidence and that it’s more likely than not that V.S. will decompensate if she does not continue to
take the risperidone, causing her detention at Western State to be much longer than it ordinarily
will be.
In its March 1, 2018, order, the superior court commissioner found that clear, cogent, and
convincing evidence supported three compelling interests justifying the use of antipsychotic
medication:
7
No. 51911-9-II (Consolidated with No. 52375-2-II)
4. Reasons for the Use of Antipsychotic Medication. The Petitioner has a
compelling interest in administering antipsychotic medication to the Respondent
for the following reasons:
Respondent has recently threatened, attempted or caused serious harm to
self or others and treatment with antipsychotic medication will reduce the
likelihood that Respondent will commit serious harm to self or others.
Respondent has suffered or will suffer a severe deterioration in routine
functioning that endangers Respondent’s health or safety if he/she does not
receive such treatment, as evidenced by Respondent’s past behavior and
mental condition while he/she was receiving such treatment.
Respondent will likely be detained for a substantially longer period of time,
at increased public expense, without such treatment.
5. Less Effective Alternatives. Antipsychotic medication is a necessary and
effective course of treatment for the Respondent, as evidence by Respondent’s
prognosis with and without this treatment and the lack of effective alternative
courses of treatment. The alternatives are less effective than medication for the
following reasons:
They are more likely to prolong the length of commitment for involuntary
treatment.
CP at 199. The superior court commissioner concluded,
10. The Respondent may be involuntarily treated with antipsychotic medication
and side effect medication at clinically appropriate levels over his/her objections
and over his/her express refusal for the period of the current involuntary treatment
order, and any interim period during which he/she is awaiting trial or hearing on a
new petition for involuntary treatment or involuntary medication.
CP 200. As a result, the superior court commissioner ordered the involuntary administration of
antipsychotic medications as requested in the Petition.
V.S. appeals the January 26, 2018, and March 1, 2018, orders.
8
No. 51911-9-II (Consolidated with No. 52375-2-II)
ANALYSIS
A. COMPELLING STATE INTEREST
First, V.S. argues that the superior court erred in ordering involuntary medication because
the State failed to prove compelling state interests justifying involuntary medication.1 We
disagree.
Here, the superior court found that the State had proved at least three compelling state
interests: (1) V.S. was threatening self-harm, (2) likelihood of substantial harm or deterioration,
and (3) V.S. “will likely be detained for a substantially longer period of time, at increased public
expense, without such treatment.” CP at 73, 199. In In re. Det. of B.M., 7 Wash. App. 2d 70, 80,
432 P.3d 459, review denied, 193 Wash. 2d 1017 (2019), which addressed an identical finding,2 the
court held that avoiding prolonged commitment was a compelling state interest. Because the State
1
In its briefing, the State argued that this appeal should be dismissed as moot. However, at oral
argument, the State conceded that, based on this court’s decision in B,M., this case is not moot.
Wash. Court of Appeals oral argument, In re Det. of V.S., No. 51911-9 consol. with 52375-2 (Sept.
13, 2019), at 19 min., 35 sec. to 19 min., 45 sec. (on file with court); In re. Det. of B.M., 7 Wn.
App. 2d 70, 77, 432 P.3d 459, review denied, 193 Wash. 2d 1017 (2019).
In B.M., we held that involuntary medication orders are not moot because, like involuntary
commitment orders, involuntary medication orders are part of an appellant’s mental health history
and may have adverse collateral consequences. 7 Wash. App. 2d at 77. Therefore, V.S.’s appeal of
the involuntary medication orders is not moot, and we accept the State’s concession.
2
In B.M., the appellant challenged the superior court’s finding that B.M. “‘will likely be detained
for a substantially longer period of time, at increased public expense, without such treatment.’”
B.M. 7 Wash. App. at 80.
9
No. 51911-9-II (Consolidated with No. 52375-2-II)
is only required to show one compelling state interest, this single state interest is sufficient to
support the superior court’s involuntary commitment order.3
“The Supreme Court has held that a person ‘possesses a significant liberty interest in
avoiding the unwanted administration of antipsychotic drugs under the Due Process Clause of the
Fourteenth Amendment.’” B.M., 7 Wash. App. 2d at 78 (quoting Washington v. Harper, 494 U.S.
210, 221-22, 110 S. Ct. 1028, 108 L. Ed. 2d 178 (1990)). Involuntary administration of
antipsychotic medication also implicates First Amendment rights. Id. Involuntarily committed
individuals maintain their rights to refuse antipsychotic medication. RCW 71.05.217(7).
However, RCW 71.05.217(7)(a) allows the superior court to order involuntary
administration of antipsychotic medication if the State proves, by clear, cogent, and convincing
evidence, that administration of the antipsychotic medication serves a compelling state interest, is
necessary and effective, and is required because there are no reasonable, effective alternatives. See
also B.M., 7 Wash. App. 2d at 79. There are four accepted compelling state interests that justify
involuntary medication: “‘(1) the preservation of life; (2) the protection of interests of innocent
third parties; (3) the prevention of suicide; and (4) maintenance of the ethical integrity of the
medical profession.’” Id. (internal quotation marks omitted) (quoting In re Det. of Schuoler, 106
3
V.S. also challenges the sufficiency of the evidence to support the superior court’s first and
second compelling State interest findings. However, V.S. does not argue the sufficiency of the
evidence with regard to the third compelling State interest—prolonged commitment. V.S. only
argues that the superior court’s finding that she will likely be detained for a substantially longer
period of time at public expense without forced medication is not a compelling State interest.
Because B.M. has held otherwise and is dispositive of this issue, we do not address the sufficiency
of the evidence related to the court’s compelling state interest findings.
10
No. 51911-9-II (Consolidated with No. 52375-2-II)
Wn.2d 500, 508, 723 P.2d 1103 (1986)). However, this list is not exclusive and other interests
may be as compelling as those already identified. Id. (citing Schuoler, 106 Wn.2d at 508).
In B.M., the appellant argued that the State failed to prove a compelling state interest
because the superior court found that the State’s compelling state interest was in preventing
prolonged commitment. Id. at 80. The court held that the State did have a compelling state interest
in preventing the indefinite commitment of individuals and in providing timely and appropriate
treatment. Id. at 82. The State’s interest in preventing prolonged commitment of an individual
was more than simply cost or efficiency. Id. at 82.
The court’s holding in B.M. also applies here. And V.S. does not argue the sufficiency of
the evidence supporting the superior court commissioner’s finding that she will likely be detained
for a substantially longer period of time at public expense without forced medication. See Cowiche
Canyon Conservancy v. Bosley, 118 Wash. 2d 801, 809, 828 P.3d 549 (1992) (This court will not
consider assignments of error unsupported by argument or citation to legal authority.). Instead,
V.S. only argues that preventing prolonged commitment is not a sufficiently compelling state
interest to justify involuntary medication. Because B.M. resolves this issue, we affirm the findings
of compelling state interests in both of the superior court’s orders.
B. NECESSARY AND EFFECTIVE TREATMENT
V.S. argues that the State failed to present sufficient evidence to show that involuntary
administration of antipsychotic medication was necessary and effective. We disagree.
We review challenges to the sufficiency of the evidence in the light most favorable to the
State. B.M., 7 Wash. App. 2d at 85. The State must prove by clear, cogent, and convincing evidence
that “the proposed treatment is necessary and effective” and that other alternative forms of
11
No. 51911-9-II (Consolidated with No. 52375-2-II)
treatment will not likely be effective. RCW 71.05.217(7)(a). We will not “disturb the superior
court’s findings ‘if supported by substantial evidence which the lower court could reasonably have
found to be clear, cogent, and convincing.’” B.M., 7 Wash. App. 2d at 85 (quoting In re Det. of
LaBelle, 107 Wash. 2d 196, 209, 728 P.2d 138 (1986)).
1. January 26 Order
The superior court’s January 26 order adopted the commissioner’s December 28 findings
and conclusions. The superior court commissioner found that,
5. Less Effective Alternatives. Antipsychotic medication is a necessary and
effective course of treatment for the Respondent, as evidence by Respondent’s
prognosis with and without this treatment and the lack of effective alternative
courses of treatment. The alternatives are less effective than medication for the
following reasons:
They are more likely to prolong the length of commitment for involuntary
treatment;
....
Other: If medication is administered then she is likely to make more rational
decisions, particularly about her medical situations. If not administered she
is likely to have serious health concerns, including death. Physical health
has already deteriorated to point of starting to affect her.
CP at 74. These findings were supported by substantial evidence presented at the hearing. At the
hearing, Dr. Stevens testified that antipsychotic medication would likely increase V.S.’s ability to
make rational decisions regarding her health care and diabetes treatment. And Dr. Stevens
explained that other courses of treatment would not be effective because V.S. would not cooperate
with the only alternative—psychotherapy. Therefore, sufficient evidence supports the
commissioner’s finding that antipsychotic medication is a necessary and effective course of
treatment for V.S., which was adopted by the superior court’s January 26 order.
12
No. 51911-9-II (Consolidated with No. 52375-2-II)
2. March 1 Order
In the March 1 order, the superior court commissioner found,
5. Less Effective Alternatives. Antipsychotic medication is a necessary and
effective course of treatment for the Respondent, as evidence by Respondent’s
prognosis with and without this treatment and the lack of effective alternative
courses of treatment. The alternatives are less effective than medication for the
following reasons:
They are more likely to prolong the length of commitment for involuntary
treatment.
CP at 199.
This finding was also supported by substantial evidence. At the hearing on the March 1
order, Dr. Kumar testified that the administration of the antipsychotic medication was making V.S.
more cooperative in her medical treatment for her diabetes. However, Dr. Kumar also explained
V.S. intended to stop taking the medication, which would likely result in a return to her prior
condition. And Dr. Kumar testified there was no less intrusive alternative because the medication
was the cause of V.S.’s improvement. Therefore, sufficient evidence supports the superior court
commissioner’s finding that the medication was necessary and effective.
C. CORRECT LEGAL STANDARD
V.S. argues that the superior court applied the wrong legal standard when entering the
January 26, 2018, order because the commissioner found that it was only likely that V.S. was
refusing diabetes treatment due to delusions and psychosis. We disagree.
V.S.’s argument relies solely on the superior court commissioner’s oral ruling regarding
V.S. refusing medical treatment. However, a court’s oral ruling “‘is no more than an expression
of its informal opinion at the time it is rendered.’” State v. Friedlund, 182 Wash. 2d 388, 394, 341
13
No. 51911-9-II (Consolidated with No. 52375-2-II)
P.3d 280 (2015) (quoting State v. Mallory, 69 Wash. 2d 532, 533-34, 419 P.2d 324 (1966)); see also
B.M., 7 Wash. App. 2d at 84. The trial court’s written judgment “is a final order subject to appeal.”
Friedlund, 182 Wash. 2d at 395.
Here, the superior court commissioner’s written order explicitly stated that its findings
were made by clear, cogent, and convincing evidence. And the superior court adopted and
incorporated the commissioner’s written order into its order. Therefore, the final order subject to
appeal applied the correct legal standard.
D. MAXIMUM DOSAGES
Finally, V.S. argues that the superior court’s order is invalid because it does not identify
the maximum permitted dosages of medication allowed under the order. V.S. relies on United
States v. Hernandez-Vasquez, 513 F.3d 908, 916-17 (9th Cir. 2008) and United States v. Williams,
356 F.3d 1045 (9th Cir. 2004), to support her argument. We disagree.
Although limitations on maximum dosages are required for Sell4 orders authorizing
involuntary medication to restore competency, those requirements do not apply to involuntary
medication orders for civil commitments. B.M., 7 Wash. App. 2d at 90-91. Because Sell,
Hernandez-Vasquez, and Williams do not apply to civil commitments,5 the failure to identify a
maximum dosage is not a due process violation in the civil commitment context. B.M., 7 Wn.
App. 2d at 91. And an appellant subject to civil commitment may not raise the superior court’s
4
Sell v. United States, 539 U.S. 166, 123 S. Ct. 2174, 156 L. Ed. 2d 197 (2003).
5
Sell and Hernandez-Vasquez addressed involuntary medication orders for the purpose of
restoring competence for criminal trials. Sell, 539 U.S. at 171; Hernandez-Vasquez, 513 F.3d at
911-12. Williams addressed involuntary medication as a condition of community supervision
following a criminal conviction. 356 F.3d at 1050-51.
14
No. 51911-9-II (Consolidated with No. 52375-2-II)
failure to include a maximum dosage for the first time on appeal. B.M., 7 Wash. App. 2d at 91; RAP
2.5(a).
Here, V.S. did not object to the superior court’s failure to include a maximum dosages on
either involuntary medication order. Therefore, as held in B.M., V.S. may not now raise the
superior court’s failure to include maximum dosages in the order for the first time on appeal.
We affirm.
A majority of the panel having determined that this opinion will not be printed in the
Washington Appellate Reports, but will be filed for public record in accordance with RCW 2.06.040,
it is so ordered.
Lee, A.C.J.
We concur:
Worswick, J.
Cruser, J.
15